Lehnert M, Eberle A, Hentschel S, Katalinic A, Kieschke J, Schmidtmann I, Schubert-Fritschle G, Stegmaier C, Hense H-W
Epidemiologisches Krebsregister NRW, Münster.
Gesundheitswesen. 2005 Oct;67(10):729-35. doi: 10.1055/s-2005-858696.
To exclude bias of registration evidenced by relevant differences among German cancer registries in the incidence of malignant melanoma (melanocarcinoma).
Cancer registries in the Federal German states of Hamburg, Schleswig-Holstein, Bremen, Rhineland-Palatinate, Saarland, the Munich District and the County of Münster featured registration data of malignant melanoma diagnosed in 2000 A. D. Figures and incidence rates, distribution of T-stage of the primary tumour were analysed as well as the distribution of sources reporting melanoma to the registries. Details of outpatient treatment of cutaneous melanoma by dermatologists in private practice were investigated.
Data of 2,471 malignant melanoma cases were analysed. The highest age standardised incidence rates were 15.7 per 100,000 women and 19 per 100,000 men while the lowest rates were reported as 7.8 and 6.6 per 100,000, respectively (European standard). The proportion of stage T1 tumours varied between 21.5 and 59.2 %. We observed remarkable variations in the structure of reporting sources among the registries. The proportion of reports from dermatologists in private practice varied between 2.2 and 62 %, with higher proportions associated with more T1-T2 tumours but also lower completeness of stage reports. No clear association was identified between incidence of melanoma and reporting sources.
Malignant melanomas of smaller size (T1-T2) are reported more frequently in an outpatient setting but very often without data. Hospital departments of dermatology contribute high-quality data with better completeness especially for later stage melanomas. Desirable inclusion of notifications from nationwide operating dermatopathology laboratories is complicated by the Federal German structure of cancer registration. Especially in case of malignant melanoma of the skin notification reports from all sectors of the health care system are imperative for valid epidemiological results.
排除德国癌症登记处之间在恶性黑色素瘤(黑素瘤)发病率方面存在的相关差异所证明的登记偏差。
德国联邦州汉堡、石勒苏益格-荷尔斯泰因、不来梅、莱茵兰-普法尔茨、萨尔州、慕尼黑地区和明斯特县的癌症登记处提供了2000年诊断出的恶性黑色素瘤的登记数据。分析了病例数、发病率、原发肿瘤T分期的分布以及向登记处报告黑色素瘤的来源分布。调查了私人执业皮肤科医生对皮肤黑色素瘤的门诊治疗细节。
分析了2471例恶性黑色素瘤病例的数据。最高年龄标准化发病率为每10万女性15.7例和每10万男性19例,而最低发病率分别报告为每10万7.8例和6.6例(欧洲标准)。T1期肿瘤的比例在21.5%至59.2%之间变化。我们观察到各登记处报告来源结构存在显著差异。私人执业皮肤科医生的报告比例在2.2%至62%之间变化,比例较高与更多T1 - T2期肿瘤相关,但分期报告的完整性也较低。未发现黑色素瘤发病率与报告来源之间存在明确关联。
较小尺寸(T1 - T2)的恶性黑色素瘤在门诊环境中报告更为频繁,但往往没有数据。医院皮肤科提供的数据质量更高且完整性更好,尤其是对于晚期黑色素瘤。由于德国联邦癌症登记结构,理想情况下纳入全国性运营的皮肤病理实验室的通知较为复杂。特别是对于皮肤恶性黑色素瘤,医疗保健系统所有部门的通知报告对于有效的流行病学结果至关重要。